Alan Franklin

Company: ForwardVue Pharma
Job title: Chief Executive Officer
Seminars:
Carboxyamidotriazole Delivers Potent Anti-Angiogenic, Safe, and Durable Treatment For Neovascular Ocular Disease 3:30 pm
Carboxyamidotriazole has an extensive human safety profile after systemic administration Carboxyamidotriazole is a novel chemical entity for ocular disease Carboxyamidotriazole can be durably administered and is effective in multiple pre-clinical models of ocular neovascular diseaseRead more
day: Day Two